Trump’s scheduled White House meeting with Netanyahu on July 28 occurs amid ongoing tensions over the Iran conflict and U.S. diplomatic efforts, with reports of Trump privately criticizing the Israeli leader’s approach as overly aggressive and disruptive to peace talks. Recent public statements from Trump have mixed acknowledgment of their working relationship with pointed frustration about Israel’s handling of regional escalation, reducing expectations of fresh public praise in the narrow window before July 31. Trader positioning at 60.5% for “No” reflects this strained dynamic and the absence of any immediate catalyst for positive rhetoric, despite the upcoming bilateral engagement.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoSí
Sí
A qualifying statement includes any remark by Trump that expresses approval, admiration, respect, or endorsement of the listed individual personally or professionally. This can include direct praise (e.g., “He/She is smart,” “He’s/She's a great leader”) or equivalent positive descriptions (“impressive,” “strong,” “brilliant,” “doing a great job”) made in reference to the listed individual.
Any statement that clearly expresses approval, admiration, or endorsement of the listed individual personally qualifies for this market regardless of context (e.g., "He/She is very smart, but he/she doesn’t seem to know that this policy will harm more of his/her constituents." would qualify).
General neutrality or polite diplomatic language (e.g., “We had a good meeting”) will not qualify unless it contains a clear element of positive evaluation.
A direct reference will qualify even if the individual is not named, so long as it is reasonably clear from context that he is the subject.
Any written, verbal, or recorded usage will qualify.
The resolution source for this market will be public statements from Donald Trump.
Mercado abierto: Jul 24, 2026, 6:50 PM ET
Resolver
0x65070BE91...A qualifying statement includes any remark by Trump that expresses approval, admiration, respect, or endorsement of the listed individual personally or professionally. This can include direct praise (e.g., “He/She is smart,” “He’s/She's a great leader”) or equivalent positive descriptions (“impressive,” “strong,” “brilliant,” “doing a great job”) made in reference to the listed individual.
Any statement that clearly expresses approval, admiration, or endorsement of the listed individual personally qualifies for this market regardless of context (e.g., "He/She is very smart, but he/she doesn’t seem to know that this policy will harm more of his/her constituents." would qualify).
General neutrality or polite diplomatic language (e.g., “We had a good meeting”) will not qualify unless it contains a clear element of positive evaluation.
A direct reference will qualify even if the individual is not named, so long as it is reasonably clear from context that he is the subject.
Any written, verbal, or recorded usage will qualify.
The resolution source for this market will be public statements from Donald Trump.
Resolver
0x65070BE91...Trump’s scheduled White House meeting with Netanyahu on July 28 occurs amid ongoing tensions over the Iran conflict and U.S. diplomatic efforts, with reports of Trump privately criticizing the Israeli leader’s approach as overly aggressive and disruptive to peace talks. Recent public statements from Trump have mixed acknowledgment of their working relationship with pointed frustration about Israel’s handling of regional escalation, reducing expectations of fresh public praise in the narrow window before July 31. Trader positioning at 60.5% for “No” reflects this strained dynamic and the absence of any immediate catalyst for positive rhetoric, despite the upcoming bilateral engagement.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado



Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes